marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 12-14-2024
Ascendis Pharma A/S Financial Ratios 2011-2024 | ASND
Annual Financial Ratios Ascendis Pharma A/S
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | -19.2 | -20.1 | -29.7 | -19.8 | -10.9 | -7.0 | -11.7 | -29.6 | - | - | - |
P/S |
- | - | 947.3 | 1214.1 | 483.7 | 243.3 | 880.4 | 103.6 | 47.4 | 20.4 | - | - | - |
EPS |
- | - | - | -8.3 | -4.7 | -3.2 | -3.7 | -2.6 | -1.4 | - | - | - | - |
EV (Enterprise Value) |
579 M | 382 M | 7.12 B | 8 B | 5.95 B | 2.34 B | 1.18 B | 394 M | 344 M | 349 M | 20.4 M | 23.8 M | 22.6 M |
EBITDA per Share |
- | - | -8.25 | -6.53 | -4.87 | -3.77 | -3.32 | -2.72 | -1.74 | -0.678 | - | - | - |
EV/EBITDA |
-15.7 | -21.8 | -25.6 | -17.4 | -13.9 | -5.3 | -8.1 | -24.9 | - | - | - | ||
PEG |
- | -0.77 | -0.65 | -0.53 | -1.4 | 0.28 | 0.08 | 0.08 | 0.12 | - | - | - | |
P/B |
- | - | 8.3 | 10.1 | 10.8 | 9.2 | 7.2 | 2.7 | 3.2 | 6.2 | - | - | - |
P/CF |
- | - | -17.6 | -31.1 | -36.8 | -18.5 | -14.2 | -9.2 | -10.2 | -17.9 | - | - | - |
ROE % |
- | - | -43.41 | -49.95 | -36.51 | -46.45 | -66.18 | -38.79 | -27.36 | -21.08 | - | - | - |
ROA % |
- | - | -35.36 | -42.76 | -32.22 | -40.79 | -58.72 | -36.04 | -24.98 | -16.46 | - | - | - |
ROCE % |
- | - | -45.89 | -35.67 | -36.06 | -55.26 | -59.58 | -41.29 | -34.76 | -26.17 | - | - | - |
Current Ratio |
0.8 | 1.3 | 5.4 | 6.9 | 8.5 | 8.2 | 8.9 | 13.7 | 11.0 | 4.1 | - | - | - |
DSO |
- | - | - | - | - | - | - | 132.1 | 98.3 | 62.0 | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency
Quarterly Financial Ratios Ascendis Pharma A/S
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | - | - | - | -1.47 | -2.5 | -1.17 | - | -2.31 | -1.97 | -1.32 | - | -0.53 | -1.25 | -1.24 | - | -0.81 | -0.55 | -1.07 | - | -1.04 | -0.94 | -0.78 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | -2.26 | - | -1.77 | -2.18 | -2.32 | - | -1.5 | -1.72 | -1.53 | - | -1.13 | -1.09 | -1.3 | - | -0.91 | -1.09 | -0.91 | - | -0.97 | -0.76 | -0.73 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-37.31 | -45.39 | -34.83 | -54.37 | -35.45 | -48.25 | -52.95 | -53.30 | -44.23 | -48.03 | -39.03 | -27.86 | -20.01 | -31.18 | -38.54 | -36.67 | -29.93 | -46.69 | -52.28 | -69.71 | -57.27 | -57.27 | -40.52 | -16.24 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-18.22 | -24.89 | -22.45 | -38.22 | -28.95 | -40.58 | -45.55 | -46.71 | -38.76 | -42.18 | -33.96 | -24.70 | -18.13 | -28.27 | -34.98 | -33.48 | -27.65 | -27.65 | -17.52 | -11.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-19.97 | -28.88 | -27.79 | -42.84 | -37.92 | -45.95 | -45.08 | -46.41 | -37.04 | -44.85 | -44.62 | -35.53 | -22.81 | -35.40 | -40.18 | -46.56 | -36.39 | -51.96 | -54.94 | -60.77 | -50.29 | -50.29 | -34.72 | -15.22 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | 2.0 | 5.4 | 5.7 | 5.2 | 5.9 | 6.9 | 11.1 | 6.7 | 8.6 | 8.5 | 9.9 | 8.3 | 16.8 | 8.2 | 10.8 | 10.1 | 20.9 | 8.9 | - | - | - | 14.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in EUR currency